Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029295635> ?p ?o ?g. }
- W2029295635 endingPage "44" @default.
- W2029295635 startingPage "36" @default.
- W2029295635 abstract "Background: Antiretroviral therapy (ART) is associated with improved kidney function; however, the nucleotide reverse transcriptase inhibitor (NRTI) tenofovir disoproxil fumarate (TDF) has been associated with decreased kidney function and proteinuria. Methods: We examined changes in urine protein:creatinine (UPCR) and urine albumin:creatinine (UACR) ratios in 245 ART-naive participants in A5202 randomized in a substudy to blinded NRTI (abacavir/lamivudine, ABC/3TC, n = 124 or TDF/emtricitabine, TDF/FTC, n = 121) with open-label protease inhibitor (PI) atazanavir/ritonavir or nonnucleoside reverse transcriptase inhibitor (NNRTI) efavirenz. Results: At baseline, 18% of participants had clinically significant proteinuria (UPCR ≥200 mg/g), and 11% had clinically significant albuminuria (UACR ≥30 mg/g). The prevalence of clinically significant proteinuria and albuminuria decreased from baseline to week 96 in all treatment groups. In intention-to-treat analyses, there was a significant effect of NRTI component on fold change in UPCR (P = 0.011) and UACR (P = 0.018) from baseline to week 96, with greater improvements in participants randomized to ABC/3TC. There was no significant effect of NNRTI/PI component on fold change in UPCR (P = 0.23) or UACR (P = 0.88), and no significant interactions between NRTI and NNRTI/PI components. Conclusions: In this prespecified secondary analysis, ART initiation was associated with improvements in proteinuria and albuminuria, with significantly greater improvements in participants randomized to ABC/3TC versus TDF/FTC. These are the first data from a randomized trial to suggest that initiation of TDF/FTC may not be associated with the same degree of improvement in proteinuria and albuminuria that have been reported with other regimens. Future studies should consider the long-term clinical significance of these findings." @default.
- W2029295635 created "2016-06-24" @default.
- W2029295635 creator A5000167800 @default.
- W2029295635 creator A5000473129 @default.
- W2029295635 creator A5011484981 @default.
- W2029295635 creator A5020995139 @default.
- W2029295635 creator A5042834426 @default.
- W2029295635 creator A5049711413 @default.
- W2029295635 creator A5069188612 @default.
- W2029295635 creator A5081237345 @default.
- W2029295635 creator A5082238950 @default.
- W2029295635 date "2014-09-01" @default.
- W2029295635 modified "2023-10-16" @default.
- W2029295635 title "Changes in Proteinuria and Albuminuria With Initiation of Antiretroviral Therapy" @default.
- W2029295635 cites W1965135809 @default.
- W2029295635 cites W1967879506 @default.
- W2029295635 cites W1985198441 @default.
- W2029295635 cites W1989966812 @default.
- W2029295635 cites W2015797380 @default.
- W2029295635 cites W2020091161 @default.
- W2029295635 cites W2047119934 @default.
- W2029295635 cites W2048366382 @default.
- W2029295635 cites W2067043659 @default.
- W2029295635 cites W2068837792 @default.
- W2029295635 cites W2080152031 @default.
- W2029295635 cites W2083692806 @default.
- W2029295635 cites W2093971642 @default.
- W2029295635 cites W2134127271 @default.
- W2029295635 cites W2144095981 @default.
- W2029295635 cites W2149190120 @default.
- W2029295635 cites W2149717057 @default.
- W2029295635 cites W2152470009 @default.
- W2029295635 cites W2166409471 @default.
- W2029295635 doi "https://doi.org/10.1097/qai.0000000000000245" @default.
- W2029295635 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4134097" @default.
- W2029295635 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25117929" @default.
- W2029295635 hasPublicationYear "2014" @default.
- W2029295635 type Work @default.
- W2029295635 sameAs 2029295635 @default.
- W2029295635 citedByCount "16" @default.
- W2029295635 countsByYear W20292956352015 @default.
- W2029295635 countsByYear W20292956352016 @default.
- W2029295635 countsByYear W20292956352017 @default.
- W2029295635 countsByYear W20292956352018 @default.
- W2029295635 countsByYear W20292956352019 @default.
- W2029295635 countsByYear W20292956352020 @default.
- W2029295635 crossrefType "journal-article" @default.
- W2029295635 hasAuthorship W2029295635A5000167800 @default.
- W2029295635 hasAuthorship W2029295635A5000473129 @default.
- W2029295635 hasAuthorship W2029295635A5011484981 @default.
- W2029295635 hasAuthorship W2029295635A5020995139 @default.
- W2029295635 hasAuthorship W2029295635A5042834426 @default.
- W2029295635 hasAuthorship W2029295635A5049711413 @default.
- W2029295635 hasAuthorship W2029295635A5069188612 @default.
- W2029295635 hasAuthorship W2029295635A5081237345 @default.
- W2029295635 hasAuthorship W2029295635A5082238950 @default.
- W2029295635 hasBestOaLocation W20292956351 @default.
- W2029295635 hasConcept C126322002 @default.
- W2029295635 hasConcept C126894567 @default.
- W2029295635 hasConcept C142462285 @default.
- W2029295635 hasConcept C159047783 @default.
- W2029295635 hasConcept C159641895 @default.
- W2029295635 hasConcept C2776174234 @default.
- W2029295635 hasConcept C2778414717 @default.
- W2029295635 hasConcept C2779298103 @default.
- W2029295635 hasConcept C2779465607 @default.
- W2029295635 hasConcept C2779561371 @default.
- W2029295635 hasConcept C2779778239 @default.
- W2029295635 hasConcept C2780091579 @default.
- W2029295635 hasConcept C2780306776 @default.
- W2029295635 hasConcept C2780524789 @default.
- W2029295635 hasConcept C2781432083 @default.
- W2029295635 hasConcept C2993143319 @default.
- W2029295635 hasConcept C3013748606 @default.
- W2029295635 hasConcept C71924100 @default.
- W2029295635 hasConceptScore W2029295635C126322002 @default.
- W2029295635 hasConceptScore W2029295635C126894567 @default.
- W2029295635 hasConceptScore W2029295635C142462285 @default.
- W2029295635 hasConceptScore W2029295635C159047783 @default.
- W2029295635 hasConceptScore W2029295635C159641895 @default.
- W2029295635 hasConceptScore W2029295635C2776174234 @default.
- W2029295635 hasConceptScore W2029295635C2778414717 @default.
- W2029295635 hasConceptScore W2029295635C2779298103 @default.
- W2029295635 hasConceptScore W2029295635C2779465607 @default.
- W2029295635 hasConceptScore W2029295635C2779561371 @default.
- W2029295635 hasConceptScore W2029295635C2779778239 @default.
- W2029295635 hasConceptScore W2029295635C2780091579 @default.
- W2029295635 hasConceptScore W2029295635C2780306776 @default.
- W2029295635 hasConceptScore W2029295635C2780524789 @default.
- W2029295635 hasConceptScore W2029295635C2781432083 @default.
- W2029295635 hasConceptScore W2029295635C2993143319 @default.
- W2029295635 hasConceptScore W2029295635C3013748606 @default.
- W2029295635 hasConceptScore W2029295635C71924100 @default.
- W2029295635 hasIssue "1" @default.
- W2029295635 hasLocation W20292956351 @default.
- W2029295635 hasLocation W20292956352 @default.
- W2029295635 hasLocation W20292956353 @default.
- W2029295635 hasLocation W20292956354 @default.